State ID
Clinical Trials in Idaho
Idaho is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Idaho and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 60 actively recruiting studies with Idaho sites out of 60 registered in total. The busiest research areas in Idaho are Obesity, Hypertension, Overweight. Leading sponsors running trials in the state include National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network. By stage, Idaho trials break down as Phase 1 (4), Phase 2 (16), Phase 3 (30).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Idaho
Obesity (3)Hypertension (2)Overweight (2)Acute Myeloid Leukemia (2)Type 2 Diabetes Mellitus (2)Diabetes Mellitus, Type 2 (2)Lung Non-Small Cell Carcinoma (2)HPV (1)HPV - Anogenital Human Papilloma Virus Infection (1)Surgical Wound Infection (1)Traumatic Wound Infection (1)Metastatic Castration-Resistant Prostate Carcinoma (1)
Frequently Asked Questions — Clinical Trials in Idaho
How many clinical trials are currently recruiting in Idaho?
ClinicalMetric currently tracks 60 actively recruiting clinical trials with at least one location in Idaho. The total number of registered studies—including active but not currently enrolling trials—is 60. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Idaho?
Idaho hosts clinical trials across a broad range of medical conditions, including Obesity, Hypertension, Overweight, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Idaho serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Idaho?
To join a clinical trial in Idaho, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Idaho maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Idaho
NCT07758140 N/A
Recruiting
Comparative Self-collection for Cervical Cancer Screening Pivotal Study
Condition
HPV
Enrollment
260 pts
Location
United States
Sponsor
Mel Mont Medical
NCT07379684 Phase 1
Recruiting
A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic W...
Condition
Surgical Wound Infection
Enrollment
44 pts
Location
United States
Sponsor
Macro Biologics, Inc.
NCT07200830 Phase 3
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA ...
Condition
Metastatic Castration-Resistant Prostate Carcinoma
Enrollment
1,524 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT07160244 Phase 3
Recruiting
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregn...
Condition
Healthy
Enrollment
6,000 pts
Location
United States, Argentina, Brazil
Sponsor
Pfizer
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06059638 N/A
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Condition
Hypertension
Enrollment
316 pts
Location
United States, Australia, Belgium
Sponsor
Orchestra BioMed, Inc
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
LEO Pharma
NCT05504837 Phase 1
Recruiting
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Condition
Cystic Fibrosis
Enrollment
20 pts
Location
United States
Sponsor
Krystal Biotech, Inc.
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT05125302 Phase 3
Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets f...
Condition
Migraine
Enrollment
1,059 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
NCT06692738 Phase 3
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for...
Condition
Non-small Cell Lung Cancer
Enrollment
1,160 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07684235 Phase 3
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of ...
Condition
Obesity
Enrollment
3,200 pts
Location
United States, Australia, Japan
Sponsor
Amgen
NCT07652658 Phase 2
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Condition
Idiopathic Pulmonary Fibrosis (IPF)
Enrollment
359 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
NCT07747103 Phase 3
Recruiting
An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North ...
Condition
Hypothyroidism
Enrollment
466 pts
Location
United States
Sponsor
Neuvosyn Laboratories, LLC
NCT06999603 Phase 2
Recruiting
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respira...
Condition
Viral Pneumonia
Enrollment
550 pts
Location
United States, Belgium, France
Sponsor
Synairgen Research Ltd.
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT03150693 Phase 3
Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With N...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
303 pts
Location
United States, Canada
Sponsor
Alliance for Clinical Trials i
NCT06919718 N/A
Recruiting
Impact of Vitamin D Supplements on Mental Health and Milk Composition in Mothers...
Condition
Maternal Stress
Enrollment
80 pts
Location
United States
Sponsor
University of Idaho
NCT06998940 Phase 3
Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Adva...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
94 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT06008197 Phase 3
Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mort...
Condition
Heart Failure
Enrollment
5,200 pts
Location
United States, Argentina, Australia
Sponsor
Colorado Prevention Center
NCT07091617 N/A
Recruiting
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing ...
Condition
Miscellaneous Neoplasm, Nos
Enrollment
535 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06616584 Phase 2, Phase 3
Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Adva...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
378 pts
Location
United States
Sponsor
SWOG Cancer Research Network
Page 1 of 3 — 60 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology